De Backer Marianne 4
4 · Vir Biotechnology, Inc. · Filed Apr 4, 2023
Insider Transaction Report
Form 4
De Backer Marianne
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-04-03+576,452→ 576,452 total - Award
Stock Option (Right to Buy)
2023-04-03+1,152,904→ 1,152,904 totalExercise: $23.28Exp: 2033-04-02→ Common Stock (1,152,904 underlying)
Footnotes (2)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]25% of the shares subject to the stock option vest and become exercisable on April 3, 2024, and the remainder vest in 36 equal monthly installments thereafter.